Lymphoma: 9858 Clinical Trials, Page 753 of 986

Hide Studies Not Open or Pending

7530

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Condition(s):AIDS-Related Non-Hodgkin Lymphoma; Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Hepatocellular Carcinoma; HIV Infection; Kaposi Sarcoma; Locally Advanced Lung Non-Small Cell Carcinoma; Locally Advanced Malignant Solid Neoplasm; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Non-Hodgkin Lymphoma; Recurrent Classic Hodgkin Lymphoma; Recurrent Malignant Neoplasm; Refractory Classic Hodgkin Lymphoma; Refractory Malignant Neoplasm; Stage III Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Unresectable MelanomaLast Updated:November 3, 2023Active, not recruiting

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.